A stochastic model for evaluating the progression of ductal carcinoma in situ breast cancer using Norwegian breast cancer screening program data

Q1 Medicine
Xiaoxue Li , Harald Weedon-Fekjær , Bo Zhang , Sandra J. Lee
{"title":"A stochastic model for evaluating the progression of ductal carcinoma in situ breast cancer using Norwegian breast cancer screening program data","authors":"Xiaoxue Li ,&nbsp;Harald Weedon-Fekjær ,&nbsp;Bo Zhang ,&nbsp;Sandra J. Lee","doi":"10.1016/j.imu.2025.101647","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Following widespread mammography screening for breast cancer, the incidence of ductal carcinoma in situ (DCIS) has increased sharply. However, the value of detecting DCIS by screening is uncertain as not all DCIS progresses to invasive breast cancer. Knowledge about the sojourn time in the screen-detectable DCIS state and the progression or regression of DCIS to other stages (i.e., the natural history of DCIS) is essential to treat screen-detected DCIS lesions.</div></div><div><h3>Methods</h3><div>We developed a stochastic model for DCIS natural history, characterized by DCIS states, invasive breast cancer states, and transition probabilities between the states. The model included DCIS lesions in the screen-detectable preclinical state and their progression to clinical DCIS, invasive breast cancer, or regression to a state undetectable by screening. Unlike currently available DCIS Markov models, the proposed model assumed no relationship between the sojourn time and transition probabilities in DCIS states and used age-specific transition probabilities. In the absence of ideal data for DCIS modeling, the Norwegian Breast Cancer Screening Program data, specifically arranged by screening round and mode of detection, was applied to obtain maximum likelihood estimates of DCIS natural history parameters, including transition probabilities and the mean sojourn time in the preclinical screen-detectable DCIS state.</div></div><div><h3>Results</h3><div>By indirectly specifying a range of the proportion of breast lesions in the preclinical undetectable DCIS state (S<sub>du</sub>) that progress through the preclinical screen-detectable DCIS state (S<sub>dp</sub>), <em>P</em><sub><em>d</em></sub><em>(t)</em>, not going directly to preclinical invasive breast cancer (S<sub>p</sub>), plausible sets of DCIS natural history parameters were systematically evaluated. All estimates indicated that the mean sojourn time in S<sub>dp</sub> was relatively short (≤3.5 years). For the age group 50–54 years, the best fitting mean sojourn time in S<sub>dp</sub> was 3.4–3.5 years, with mammography sensitivity 0.60–0.61 when <em>P</em><sub><em>d</em></sub><em>(t)</em> was 0.31–0.34. When <em>P</em><sub><em>d</em></sub><em>(t)</em> was larger, mean sojourn times in S<sub>dp</sub> likely varied by the pathway. In general, assuming higher <em>P</em><sub><em>d</em></sub><em>(t)</em>—that is, a higher proportion of DCIS lesions that progress to from S<sub>dp</sub> to S<sub>p</sub>—the mean sojourn time became shorter. Regression to no cancer or undetectable state might be possible, but the quantified level of regression was associated with great uncertainties.</div></div><div><h3>Conclusion</h3><div>While difficult to point to a unique set of DCIS natural history estimates, identifying broader sets of plausible estimates is possible. Estimates reported here provide a comprehensive view of potential progression paths of DCIS while acknowledging the limitations of available data.</div></div>","PeriodicalId":13953,"journal":{"name":"Informatics in Medicine Unlocked","volume":"55 ","pages":"Article 101647"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Informatics in Medicine Unlocked","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352914825000358","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Following widespread mammography screening for breast cancer, the incidence of ductal carcinoma in situ (DCIS) has increased sharply. However, the value of detecting DCIS by screening is uncertain as not all DCIS progresses to invasive breast cancer. Knowledge about the sojourn time in the screen-detectable DCIS state and the progression or regression of DCIS to other stages (i.e., the natural history of DCIS) is essential to treat screen-detected DCIS lesions.

Methods

We developed a stochastic model for DCIS natural history, characterized by DCIS states, invasive breast cancer states, and transition probabilities between the states. The model included DCIS lesions in the screen-detectable preclinical state and their progression to clinical DCIS, invasive breast cancer, or regression to a state undetectable by screening. Unlike currently available DCIS Markov models, the proposed model assumed no relationship between the sojourn time and transition probabilities in DCIS states and used age-specific transition probabilities. In the absence of ideal data for DCIS modeling, the Norwegian Breast Cancer Screening Program data, specifically arranged by screening round and mode of detection, was applied to obtain maximum likelihood estimates of DCIS natural history parameters, including transition probabilities and the mean sojourn time in the preclinical screen-detectable DCIS state.

Results

By indirectly specifying a range of the proportion of breast lesions in the preclinical undetectable DCIS state (Sdu) that progress through the preclinical screen-detectable DCIS state (Sdp), Pd(t), not going directly to preclinical invasive breast cancer (Sp), plausible sets of DCIS natural history parameters were systematically evaluated. All estimates indicated that the mean sojourn time in Sdp was relatively short (≤3.5 years). For the age group 50–54 years, the best fitting mean sojourn time in Sdp was 3.4–3.5 years, with mammography sensitivity 0.60–0.61 when Pd(t) was 0.31–0.34. When Pd(t) was larger, mean sojourn times in Sdp likely varied by the pathway. In general, assuming higher Pd(t)—that is, a higher proportion of DCIS lesions that progress to from Sdp to Sp—the mean sojourn time became shorter. Regression to no cancer or undetectable state might be possible, but the quantified level of regression was associated with great uncertainties.

Conclusion

While difficult to point to a unique set of DCIS natural history estimates, identifying broader sets of plausible estimates is possible. Estimates reported here provide a comprehensive view of potential progression paths of DCIS while acknowledging the limitations of available data.
使用挪威乳腺癌筛查项目数据评估导管原位癌进展的随机模型
背景:随着乳房x线摄影对乳腺癌的广泛筛查,导管原位癌(DCIS)的发病率急剧上升。然而,通过筛查发现DCIS的价值尚不确定,因为并非所有DCIS都进展为浸润性乳腺癌。了解筛查到的DCIS状态的停留时间以及DCIS向其他阶段的进展或倒退(即DCIS的自然史)对于治疗筛查到的DCIS病变至关重要。方法我们建立了一个DCIS自然史的随机模型,以DCIS状态、浸润性乳腺癌状态和状态之间的转移概率为特征。该模型包括筛查可检测到的临床前DCIS病变及其进展为临床DCIS、浸润性乳腺癌或退至筛查无法检测到的状态。与现有的DCIS马尔可夫模型不同,该模型没有假设DCIS状态的停留时间和转移概率之间的关系,而是使用特定年龄的转移概率。在缺乏理想的DCIS建模数据的情况下,我们应用挪威乳腺癌筛查项目的数据,根据筛查轮和检测方式进行了特别安排,以获得DCIS自然史参数的最大似然估计,包括转移概率和临床前筛查可检测到的DCIS状态的平均停留时间。结果通过间接指定临床前无法检测到的DCIS状态(Sdu)的乳腺病变的比例范围,通过临床前可筛查的DCIS状态(Sdp), Pd(t),而不是直接进入临床前浸润性乳腺癌(Sp),系统地评估了DCIS自然史参数的合理集合。所有的估计表明,在Sdp的平均逗留时间相对较短(≤3.5年)。对于50-54岁年龄组,最佳拟合的平均Sdp停留时间为3.4-3.5年,当Pd(t)为0.31-0.34时,乳房x线摄影灵敏度为0.60-0.61。当Pd(t)较大时,Sdp的平均停留时间可能因途径而异。一般来说,假设Pd(t)较高,即从Sdp发展到sp的DCIS病变比例较高,则平均停留时间变短。回归到无癌或检测不到的状态是可能的,但回归的量化水平与很大的不确定性有关。结论:虽然很难得出一组独特的DCIS自然历史估计,但确定更广泛的合理估计是可能的。在承认现有数据的局限性的同时,本文报告的估计提供了DCIS潜在进展路径的全面视图。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Informatics in Medicine Unlocked
Informatics in Medicine Unlocked Medicine-Health Informatics
CiteScore
9.50
自引率
0.00%
发文量
282
审稿时长
39 days
期刊介绍: Informatics in Medicine Unlocked (IMU) is an international gold open access journal covering a broad spectrum of topics within medical informatics, including (but not limited to) papers focusing on imaging, pathology, teledermatology, public health, ophthalmological, nursing and translational medicine informatics. The full papers that are published in the journal are accessible to all who visit the website.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信